OrthoPediatrics Corp. Forecast, price target & analysts
OrthoPediatrics Corp. Target price 2026 - Analyst rating & recommendation
OrthoPediatrics Corp. Classifications & Recommendation
OrthoPediatrics Corp. Price Target
| Target Price | $25.50 |
| Price | $22.89 |
| Potential |
11.40%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target OrthoPediatrics Corp. 2027 .
The average OrthoPediatrics Corp. target price is $25.50.
This is
11.40%
register free of charge
$36.75
60.55%
register free of charge
$22.22
2.93%
register free of charge
|
|
| A rating was issued by 15 analysts: 13 Analysts recommend OrthoPediatrics Corp. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the OrthoPediatrics Corp. stock has an average upside potential 2027 of
11.40%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 236.35 | 272.32 |
| 15.44% | 15.22% | |
| EBITDA Margin | -7.18% | 9.35% |
| 20.80% | 230.15% | |
| Net Margin | -16.78% | -11.96% |
| 9.19% | 28.71% |
11 Analysts have issued a sales forecast OrthoPediatrics Corp. 2026 . The average OrthoPediatrics Corp. sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an OrthoPediatrics Corp. EBITDA forecast 2026. The average OrthoPediatrics Corp. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 OrthoPediatrics Corp. Analysts have issued a net profit forecast 2026. The average OrthoPediatrics Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.69 | -1.25 |
| 3.05% | 26.04% | |
| P/E | negative | |
| EV/Sales | 2.39 |
11 Analysts have issued a OrthoPediatrics Corp. forecast for earnings per share. The average OrthoPediatrics Corp. EPS is
This results in the following potential growth metrics and future valuations:
OrthoPediatrics Corp....
Current OrthoPediatrics Corp. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Sep 14 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Aug 20 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jul 16 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | May 01 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Mar 02 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 14 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 20 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jul 16 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
May 01 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Mar 02 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
